https://www.thebodypro.com/article/fda-to-evaluate-potential-risk-of-neural-tube-birt
Dolutegravir (Tivicay)News

FDA to Evaluate Potential Risk of Neural Tube Birth Defects With HIV Medicine Dolutegravir (Juluca, Tivicay, Triumeq)

    U.S. Food and Drug Administration

    U.S. Food and Drug Administration